Clinical Trial Update: Efficacy and Safety Study on bIAP [Phase 3]

View source ↗

Summary

A Phase 3 efficacy and safety trial of the drug bIAP has completed, studying patients with coronary artery disease and endotoxin-mediated complications after ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Endotoxin-mediated Complications From Cardiopulmonary Bypass Surgery

Drugs mentioned

• bIAP

Snippet

Sponsor: Catharina Ziekenhuis Eindhoven | Conditions: Coronary Artery Disease, Endotoxin-mediated Complications From Cardiopulmonary Bypass Surgery | Phase 3 | Status: COMPLETED